AOCPMR 2022 Mid-Year Meeting-306289

Video Transcription

Video Summary

The conference section transitioned to a discussion on neurological approaches to spasticity management, led by Dr. Kramer. He elaborated on the use of intrathecal baclofen for managing severe spasticity stemming from various conditions including spinal cord injury, cerebral palsy, and strokes. The treatment involves delivering baclofen directly into the spinal fluid, requiring lower medication dosages and reducing side effects compared to oral treatments. Various treatment modalities were covered, such as rehabilitation, oral medications, injection therapies (including Botox and Phenol), and lastly, intrathecal therapy. Dr. Kramer emphasized that while spasticity doesn't always require treatment, especially if it aids in ambulation or muscle tone maintenance, severe cases impacting quality of life should be addressed. He explained the evaluation and selection process for patients who might benefit from intrathecal therapy, focusing on their medical and social readiness for such treatment. Dr. Kramer also shared his experiences with specialized treatments, like the combination of different drugs within the pump for complex cases, and the critical importance of having a support system for pump management to prevent complications like baclofen withdrawal. A recent study on stroke patients indicated significant reductions in muscle tone and improvements in pain and quality of life through intrathecal baclofen therapy, underscoring its potential benefits despite associated surgical risks.

Keywords

neurological approaches

spasticity management

intrathecal baclofen

spinal cord injury

cerebral palsy

strokes

rehabilitation

injection therapies

quality of life

treatment modalities

baclofen withdrawal